NEUROFIBROMATOSIS 1

Clinical trials for NEUROFIBROMATOSIS 1 explained in plain language.

Never miss a new study

Get alerted when new NEUROFIBROMATOSIS 1 trials appear

Sign up with your email to follow new studies for NEUROFIBROMATOSIS 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 10 Completed 7 Terminated 1

Light-Activated cream could slow growth of NF1 skin tumors

Disease control Terminated

This trial tests whether a light-activated cream (Levulan Kerastick) followed by red light therapy can slow the growth of benign skin tumors called neurofibromas in people with neurofibromatosis type 1 (NF1). About 30 participants aged 14 and older with superficial tumors on the …

Matched conditions: NEUROFIBROMATOSIS 1

Phase: PHASE2 • Sponsor: Donald Basel • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC

NEUROFIBROMATOSIS 1

Get alerted when new NEUROFIBROMATOSIS 1 trials appear

Light-Activated cream could slow growth of NF1 skin tumors